ITA ENG
Enter at least 3 characters
Home > News

Autorizzo al trattamento dei miei dati personali
ai sensi del D.L. 30 giugno 2003 n. 196
Edit email address
Invalid email
Text email send
Authorize the processing of personal data
ARCHIVE NEWS
Global Corporate Development : opening of new offices in Boston
16 Marzo 2018
Chiesi Digital Transformation - Digital Safari Workshop with David Orban
24 Gennaio 2018
Chiesi enters into an Exclusive ex-US Partnership with Protalix BioTherapeutics for the Development and Commercialization of PRX-102 (pegunigalsidase alfa) for the Treatment of Fabry Disease
20 Ottobre 2017
Chiesi certified Top Employer also for 2017
13 Febbraio 2017
Chiesi is Top Employer again!
15 Febbraio 2016
Alberto, Paolo and Andrea Chiesi winners of the “Entrepreneur of the year 2015” Award
30 Novembre 2015
Special Mention to Holoclar at the Italian Galeno Award
26 Novembre 2015
COPD indication for Foster pMDI
21 Marzo 2014
Double-digit growth and internal expansion for the Chiesi Group
14 Marzo 2014
© 2018 CHIESI Farmaceutici S.p.A.
Vat 01513360345
Payed Up Capital: Euro 75.000.000
Companies Register Office - Parma N.15739
REA: 159271
CHIESI ON THE WEB

follow us on: